Nurse Practitioner · Topeka, KS
NPI
1811329774
Since 2013
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
901 SW Garfield Ave
Topeka, KS, 66606
Phone (785) 354-9591
Groups this clinician bills Medicare through
Medicare paid, 2024
$177K
5,448 services
Medicare patients, 2024
379
Average age 73
Drug cost, 2024
$408K
7,139 prescriptions
Company payments, 2025
$935
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristin K Poage was code J0897 (injection, denosumab, 1 mg), 2,640 times for 27 patients. In total Kristin K Poage billed 5,448 services in 41 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,640 | 27 | $20.44 | $54K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 514 | 57 | $37.34 | $19K |
| 99214 Office E&M - Established | Office | 450 | 258 | $66.49 | $30K |
| 36415 Venipuncture Blood Collection | Office | 435 | 307 | $8.65 | $3,763 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 307 | 307 | $101.47 | $31K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 220 | 47 | $28.90 | $6,358 |
| 99213 Office E&M - Established | Office | 197 | 176 | $37.25 | $7,338 |
| 96372 Injection Administration | Office | 69 | 33 | $8.37 | $578 |
| G0008 Administration of influenza virus vaccine | Office | 53 | 52 | $24.50 | $1,299 |
| 90653 Vaccine Product | Office | 45 | 45 | $81.82 | $3,682 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 37 | 13 | $43.58 | $1,612 |
| 83036 Blood Count | Office | 36 | 33 | $9.52 | $343 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 25 | 21 | $31.93 | $798 |
| 99215 Office E&M - Established | Office | 20 | 17 | $76.63 | $1,533 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 18 | 13 | $75.44 | $1,358 |
By year: 2022 $80K for 2,233 services; 2023 $114K for 3,243 services; 2024 $177K for 5,448 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 435 | 307 | $8.65 | $3,763 |
| 83036 Blood Count | 36 | 33 | $9.52 | $343 |
| 81002 Clinical Chemistry | 16 | 14 | $3.41 | $54.56 |
Medicare prescription drug claims, 2024
In 2024, the drug Kristin K Poage prescribed most often to Medicare patients was Levothyroxine Sodium, with 369 prescriptions and refills. In total Kristin K Poage wrote 7,139 Medicare prescriptions that cost $408K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 369 | 880 | 81 | $2,846 |
| Atorvastatin Calcium Generic | 367 | 1,012 | 110 | $2,918 |
| Omeprazole Generic | 266 | 649 | 69 | $2,656 |
| Amlodipine Besylate Generic | 262 | 694 | 77 | $1,261 |
| Lisinopril Generic | 232 | 617 | 68 | $1,738 |
| Rosuvastatin Calcium Generic | 211 | 615 | 64 | $2,208 |
| Gabapentin Generic | 197 | 451 | 57 | $2,703 |
| Losartan Potassium Generic | 185 | 530 | 56 | $1,959 |
| Simvastatin Generic | 149 | 434 | 43 | $816 |
| Pantoprazole Sodium Generic | 133 | 372 | 39 | $1,678 |
| Duloxetine Hcl Generic | 127 | 293 | 25 | $2,525 |
| Metoprolol Succinate Generic | 121 | 323 | 33 | $1,296 |
| Allopurinol Generic | 114 | 225 | 24 | $747 |
| Hydrochlorothiazide Generic | 106 | 274 | 31 | $809 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 102 | 106 | 40 | $2,201 |
Brand drugs: 796 claims; generic drugs: 6,304 claims; opioid claims: 160.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristin K Poage $935 ($935 in general payments such as food, travel and fees) from 15 companies. The largest payer was Pfizer Inc. with $203.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 14 | $203 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $176 |
| Lilly USA, LLC LLY | 5 | $94.68 |
| Dexcom, Inc. DXCM | 4 | $85.33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $61.67 |
| GlaxoSmithKline, LLC. GSK | 3 | $56.88 |
| Novo Nordisk Inc NVO | 3 | $48.69 |
| Abbvie Inc. ABBV | 2 | $40.35 |
| Dynavax Technologies Corporation DVAX | 2 | $34.98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $31.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.